A

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

278 employees

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical

Biotechnology

Topical Drugs

Bioscience

Biopharma

Medical Dermatology

Health Diagnostics

Eczema

Commercialization

Clinical Trials

Atopic Dermatitis

Therapeutics

Immunology

Drug Development

Plaque Psoriasis

Inflammation

Date founded

2016

Funding rounds raised

Total raised

$225M

from 9 investors over 9 rounds

A

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $225M on December 23, 2021

Investors: Solar Capital Ltd

A

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $95M on October 22, 2019

Investors: Omega Funds, OrbiMed Advisors, RA Capital Management, L.P., Vivo Capital and Frazier Healthcare Partners

A

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $58M on September 1, 2018

Investors: Frazier Healthcare Partners and OrbiMed Advisors

A

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) raised $14M on April 1, 2017

Investors: Frazier Healthcare Partners